共 50 条
- [1] Real-World Use of Sotrovimab for Pre-Emptive Treatment in High-Risk Hospitalized COVID-19 Patients: An Observational Cross-Sectional StudyANTIBIOTICS-BASEL, 2022, 11 (03):Ong, Sean W. X.论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, Singapore Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, SingaporeRen, Dongdong论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, Singapore Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, SingaporeLee, Pei Hua论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, Singapore Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, SingaporeSutjipto, Stephanie论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, Singapore Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, SingaporeDugan, Christopher论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, Singapore Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, SingaporeKhoo, Bo Yan论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, Singapore Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, SingaporeTay, Jun Xin论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, Singapore Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, SingaporeVasoo, Shawn论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, Singapore Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 308232, Singapore Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, SingaporeYoung, Barnaby E.论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, Singapore Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 308232, Singapore Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, SingaporeLye, David C.论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, Singapore Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 308232, Singapore Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117597, Singapore Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, Singapore
- [2] Real-world effectiveness of sotrovimab and remdesivir for early treatment of high-risk hospitalized COVID-19 patients: A propensity score adjusted retrospective cohort studyJOURNAL OF MEDICAL VIROLOGY, 2023, 95 (02)Koh, Lin Pin论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, Singapore, Singapore Anglo Chinese Sch Independent, Singapore, Singapore Natl Ctr Infect Dis, Singapore, SingaporeChua, Siang Li论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, Singapore, Singapore Natl Ctr Infect Dis, Singapore, SingaporeVasoo, Shawn论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, Singapore, Singapore Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore Natl Ctr Infect Dis, Singapore, SingaporeToh, Matthias Paul Han Sim论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, Singapore, Singapore Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore Natl Ctr Infect Dis, Singapore, SingaporeCutter, Jeremy Nicholas论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, Singapore, Singapore Natl Ctr Infect Dis, Singapore, SingaporeNah, Puay Hoon论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, Singapore, Singapore Natl Ctr Infect Dis, Singapore, SingaporeLeo, Yee-Sin论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, Singapore, Singapore Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore Natl Ctr Infect Dis, Singapore, SingaporeTay, Jun Xin论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, Singapore, Singapore Natl Ctr Infect Dis, Singapore, SingaporeYoung, Barnaby Edward论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, Singapore, Singapore Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore Natl Ctr Infect Dis, Singapore, SingaporeLye, David C.论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, Singapore, Singapore Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore Natl Ctr Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, Singapore Natl Ctr Infect Dis, Singapore, SingaporeOng, Sean W. X.论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, Singapore, Singapore Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore Natl Ctr Infect Dis, Singapore, Singapore
- [3] Real-world effectiveness of sotrovimab for the early treatment of COVID-19 in the USEUROPEAN RESPIRATORY JOURNAL, 2022, 60Reyes, C.论文数: 0 引用数: 0 h-index: 0机构: Vir Biotechnol, San Francisco, CA USA Vir Biotechnol, San Francisco, CA USACheng, M.论文数: 0 引用数: 0 h-index: 0机构: Vir Biotechnol, San Francisco, CA USA Vir Biotechnol, San Francisco, CA USAGibbons, D.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Brentford, England Vir Biotechnol, San Francisco, CA USABirch, H.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Brentford, England Vir Biotechnol, San Francisco, CA USAPatel, V.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Brentford, England Vir Biotechnol, San Francisco, CA USABell, C.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC USA Vir Biotechnol, San Francisco, CA USADrysdale, M.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Brentford, England Vir Biotechnol, San Francisco, CA USASatram, S.论文数: 0 引用数: 0 h-index: 0机构: Vir Biotechnol, San Francisco, CA USA Vir Biotechnol, San Francisco, CA USA
- [4] Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community SettingVIRUSES-BASEL, 2023, 15 (03):Mutoh, Yoshikazu论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanUmemura, Takumi论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Infect Control Team, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanNishikawa, Takeshi论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanKondo, Kaho论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanNishina, Yuta论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanSoejima, Kazuaki论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanNoguchi, Yoichiro论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanBando, Tomohiro论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanOta, Sho论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanShimahara, Tatsuki论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanHirota, Shuko论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanHagimoto, Satoshi论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanTakei, Reoto论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanFukihara, Jun论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanSasano, Hajime论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanYamano, Yasuhiko论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanYokoyama, Toshiki论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanKataoka, Kensuke论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanMatsuda, Toshiaki论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanKimura, Tomoki论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanIchihara, Toshihiko论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Control Team, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, JapanKondoh, Yasuhiro论文数: 0 引用数: 0 h-index: 0机构: Tosei Gen Hosp, Dept Resp Med & Allergy, Seto 4898642, Japan Tosei Gen Hosp, Dept Infect Dis, Seto 4898642, Japan
- [5] Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 PatientsJOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (35)Kim, Min-Kyung论文数: 0 引用数: 0 h-index: 0机构: Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South Korea Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South KoreaLee, Kyung-Shin论文数: 0 引用数: 0 h-index: 0机构: Natl Med Ctr, Publ Hlth Res Inst, Seoul, South Korea Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South KoreaHam, Sin Young论文数: 0 引用数: 0 h-index: 0机构: Seoul Vet Hosp, Med Ctr, Seoul, South Korea Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South KoreaChoi, Youn Young论文数: 0 引用数: 0 h-index: 0机构: Natl Med Ctr, Dept Pediat, Seoul, South Korea Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South KoreaLee, Eunyoung论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South KoreaLee, Seungjae论文数: 0 引用数: 0 h-index: 0机构: Seoul Vet Hosp, Med Ctr, Seoul, South Korea Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South KoreaLee, Bora论文数: 0 引用数: 0 h-index: 0机构: Natl Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, Seoul, South Korea Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South KoreaJeon, Jaehyun论文数: 0 引用数: 0 h-index: 0机构: Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South Korea Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South KoreaChin, Bumsik论文数: 0 引用数: 0 h-index: 0机构: Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South Korea Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South KoreaKim, Yeonjae论文数: 0 引用数: 0 h-index: 0机构: Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South Korea Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South KoreaKim, Gayeon论文数: 0 引用数: 0 h-index: 0机构: Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South Korea Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South KoreaJang, Hee -Chang论文数: 0 引用数: 0 h-index: 0机构: Korea Dis Control & Prevent Agcy, Natl Inst Infect Dis, Korea Natl Inst Hlth, Cheongju, South Korea Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South KoreaChoi, Jae-Phil论文数: 0 引用数: 0 h-index: 0机构: Seoul Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South Korea Seoul Med Ctr, Dept Internal Med, Div Infect Dis, 156 Shinnae Ro, Seoul 02053, South Korea Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South KoreaPark, Sang -Won论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea Natl Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South Korea
- [6] The Prevention of COVID-19 in High-Risk Patients Using Tixagevimab-Cilgavimab (Evusheld): Real-World Experience at a Large Academic CenterAMERICAN JOURNAL OF MEDICINE, 2023, 136 (01): : 96 - 99Al-Obaidi, Mohanad M.论文数: 0 引用数: 0 h-index: 0机构: Univ Arizona, Coll Med, Div Infect Dis, 1501 N Campbell Ave, Tucson, AZ 85721 USA Univ Arizona, Coll Med, Div Infect Dis, 1501 N Campbell Ave, Tucson, AZ 85721 USAGungor, Ahmet B.论文数: 0 引用数: 0 h-index: 0机构: Banner Univ, Div Nephrol, Med Ctr, Tucson, AZ USA Univ Arizona, Coll Med, Div Infect Dis, 1501 N Campbell Ave, Tucson, AZ 85721 USAKurtin, Sandra E.论文数: 0 引用数: 0 h-index: 0机构: Univ Arizona, Coll Med, Div Hematol & Oncol, Tucson, AZ USA Univ Arizona, Coll Med, Div Infect Dis, 1501 N Campbell Ave, Tucson, AZ 85721 USAMathias, Ann E.论文数: 0 引用数: 0 h-index: 0机构: Univ Arizona, Coll Med, Div Infect Dis, 1501 N Campbell Ave, Tucson, AZ 85721 USATanriover, Bekir论文数: 0 引用数: 0 h-index: 0机构: Univ Arizona, Coll Med, Div Nephrol, Tucson, AZ USA Univ Arizona, Coll Med, Div Infect Dis, 1501 N Campbell Ave, Tucson, AZ 85721 USAZangeneh, Tirdad T.论文数: 0 引用数: 0 h-index: 0机构: Univ Arizona, Coll Med, Div Infect Dis, 1501 N Campbell Ave, Tucson, AZ 85721 USA Univ Arizona, Coll Med, Div Infect Dis, 1501 N Campbell Ave, Tucson, AZ 85721 USA
- [7] US Real-World Effectiveness Study of Nirmatrelvir/Ritonavir in Preventing Hospitalization of High-Risk COVID-19 PatientsCURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2024, 101Cullen, Mark R.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Global Med Epidemiol, Worldwide Med & Safety, 66 Hudson Blvd E, New York, NY 10001 USAZhou, Xiaofeng论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Global Med Epidemiol, Worldwide Med & Safety, 66 Hudson Blvd E, New York, NY 10001 USA Pfizer Inc, Global Med Epidemiol, Worldwide Med & Safety, 66 Hudson Blvd E, New York, NY 10001 USAKelly, Scott P.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Global Med Epidemiol, Worldwide Med & Safety, 66 Hudson Blvd E, New York, NY 10001 USALiang, Caihua论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Global Med Epidemiol, Worldwide Med & Safety, 66 Hudson Blvd E, New York, NY 10001 USALi, Ling论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Global Med Epidemiol, Worldwide Med & Safety, 66 Hudson Blvd E, New York, NY 10001 USAShen, Rongjun论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Global Med Epidemiol, Worldwide Med & Safety, 66 Hudson Blvd E, New York, NY 10001 USALeister-Tebbe, Heidi K.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Global Med Epidemiol, Worldwide Med & Safety, 66 Hudson Blvd E, New York, NY 10001 USATerra, Steven G.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Global Med Epidemiol, Worldwide Med & Safety, 66 Hudson Blvd E, New York, NY 10001 USAGaffney, Michael论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Global Med Epidemiol, Worldwide Med & Safety, 66 Hudson Blvd E, New York, NY 10001 USARusso, Leo论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Global Med Epidemiol, Worldwide Med & Safety, 66 Hudson Blvd E, New York, NY 10001 USA
- [8] Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic electronic health recordsPLOS ONE, 2024, 19 (07):Bell, Christopher F.论文数: 0 引用数: 0 h-index: 0机构: GSK, Durham, NC 27701 USA GSK, Durham, NC 27701 USAGibbons, Daniel C.论文数: 0 引用数: 0 h-index: 0机构: GSK, Brentford, England GSK, Durham, NC 27701 USADrysdale, Myriam论文数: 0 引用数: 0 h-index: 0机构: GSK, Brentford, England GSK, Durham, NC 27701 USABirch, Helen J.论文数: 0 引用数: 0 h-index: 0机构: GSK, Brentford, England GSK, Durham, NC 27701 USALloyd, Emily J.论文数: 0 引用数: 0 h-index: 0机构: GSK, Brentford, England GSK, Durham, NC 27701 USAPatel, Vishal论文数: 0 引用数: 0 h-index: 0机构: GSK, Brentford, England GSK, Durham, NC 27701 USACarpenter, Corinne论文数: 0 引用数: 0 h-index: 0机构: nference, Cambridge, MA USA GSK, Durham, NC 27701 USACarlson, Katherine论文数: 0 引用数: 0 h-index: 0机构: nference, Cambridge, MA USA GSK, Durham, NC 27701 USACalay, Ediz S.论文数: 0 引用数: 0 h-index: 0机构: nference, Cambridge, MA USA GSK, Durham, NC 27701 USAPuranik, Arjun论文数: 0 引用数: 0 h-index: 0机构: nference, Cambridge, MA USA GSK, Durham, NC 27701 USAWagner, Tyler E.论文数: 0 引用数: 0 h-index: 0机构: nference, Cambridge, MA USA GSK, Durham, NC 27701 USAO'Horo, John C.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA GSK, Durham, NC 27701 USARazonable, Raymund R.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA GSK, Durham, NC 27701 USA
- [9] COVID-19: THE REAL-WORLD HOSPITALIZED PATIENT EXPERIENCEVALUE IN HEALTH, 2021, 24 : S116 - S116Rasouliyan, L.论文数: 0 引用数: 0 h-index: 0机构: OMNY Hlth, Atlanta, GA USA OMNY Hlth, Atlanta, GA USAKumar, V论文数: 0 引用数: 0 h-index: 0机构: OMNY Hlth, Atlanta, GA USA OMNY Hlth, Atlanta, GA USALong, S.论文数: 0 引用数: 0 h-index: 0机构: OMNY Hlth, Atlanta, GA USA OMNY Hlth, Atlanta, GA USARao, M. B.论文数: 0 引用数: 0 h-index: 0机构: OMNY Hlth, Atlanta, GA USA OMNY Hlth, Atlanta, GA USA
- [10] Children with COVID-19: The real-world hospital experiencePHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 371 - 371Rasouliyan, Lawrence论文数: 0 引用数: 0 h-index: 0机构: Mitesh B Rao OMNY Hlth, Atlanta, GA USA Mitesh B Rao OMNY Hlth, Atlanta, GA USAKumar, Vikas论文数: 0 引用数: 0 h-index: 0机构: Mitesh B Rao OMNY Hlth, Atlanta, GA USA Mitesh B Rao OMNY Hlth, Atlanta, GA USAAlthoff, Amanda G.论文数: 0 引用数: 0 h-index: 0机构: Mitesh B Rao OMNY Hlth, Atlanta, GA USA Mitesh B Rao OMNY Hlth, Atlanta, GA USALong, Stacey论文数: 0 引用数: 0 h-index: 0机构: Mitesh B Rao OMNY Hlth, Atlanta, GA USA Mitesh B Rao OMNY Hlth, Atlanta, GA USA